tiprankstipranks
Advertisement
Advertisement

ABEO Stock Latest News

Abeona Therapeutics Adds Keith Goldan to Board, Audit Chair
Company AnnouncementsAbeona Therapeutics Adds Keith Goldan to Board, Audit Chair
27d ago
8K
ABEO
Abeona Therapeutics Tightens Shareholder Meeting and Governance Rules
PremiumCompany Announcements
Abeona Therapeutics Tightens Shareholder Meeting and Governance Rules
1M ago
8K
ABEO
Early-Stage ZEVASKYN Momentum and Attractive Economics Underscore Abeona’s Undervalued Growth Potential and $20 Buy Rating
PremiumRatings
Early-Stage ZEVASKYN Momentum and Attractive Economics Underscore Abeona’s Undervalued Growth Potential and $20 Buy Rating
2M ago
ABEO
Abeona Therapeutics Balances Big Windfall With Slow Ramp
PremiumCompany Announcements
Abeona Therapeutics Balances Big Windfall With Slow Ramp
2M ago
ABEO
Abeona Therapeutics price target lowered to $20 from $27.50 at Alliance Global
PremiumThe Fly
Abeona Therapeutics price target lowered to $20 from $27.50 at Alliance Global
2M ago
ABEO
Options Volatility and Implied Earnings Moves Today, March 17, 2026
PremiumMarket NewsOptions Volatility and Implied Earnings Moves Today, March 17, 2026
2M ago
ASO
TME
Abeona Therapeutics reports 2025 EPS $1.01 vs. ($1.55) last year
Premium
The Fly
Abeona Therapeutics reports 2025 EPS $1.01 vs. ($1.55) last year
2M ago
ABEO
Options Volatility and Implied Earnings Moves This Week, March 16 – March 20, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves This Week, March 16 – March 20, 2026
2M ago
M
MU
ABEO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
ABEO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
ABEO
Early ZEVASKYN Launch Traction and Robust Reimbursement Support Abeona Buy Rating and $20 Target
PremiumRatings
Early ZEVASKYN Launch Traction and Robust Reimbursement Support Abeona Buy Rating and $20 Target
2M ago
ABEO
Abeona Accelerates ZEVASKYN Commercial Momentum and Market Access
PremiumCompany Announcements
Abeona Accelerates ZEVASKYN Commercial Momentum and Market Access
2M ago
8K
ABEO
Abeona Therapeutics provides business update on momentum in Zevaskyn launch
PremiumThe Fly
Abeona Therapeutics provides business update on momentum in Zevaskyn launch
2M ago
ABEO
3 Best Stocks to Buy Today, 2/3/2026, According to Top Analysts
PremiumMarket News3 Best Stocks to Buy Today, 2/3/2026, According to Top Analysts
3M ago
ABEO
AFRM
Abeona Therapeutics: Advancing UX111 Toward First-to-Market Approval and Scaling ZEVASKYN Launch to Near-Term Profitability
Premium
Ratings
Abeona Therapeutics: Advancing UX111 Toward First-to-Market Approval and Scaling ZEVASKYN Launch to Near-Term Profitability
3M ago
ABEO
Aehr, Fastenal, Regions, Abeona, Taysha: Insider Firestorm
Premium
Weekend Updates
Aehr, Fastenal, Regions, Abeona, Taysha: Insider Firestorm
3M ago
RF
ABEO
Dave & Buster’s, American Eagle, Cabaletta, Abeona, Oncolytics Insider Shock
PremiumWeekend Updates
Dave & Buster’s, American Eagle, Cabaletta, Abeona, Oncolytics Insider Shock
3M ago
AEO
ABEO
Abeona Therapeutics announces employee inducement grants
PremiumThe Fly
Abeona Therapeutics announces employee inducement grants
4M ago
ABEO
Abeona Therapeutics appoints Mohamad Tabrizi as CBO
PremiumThe Fly
Abeona Therapeutics appoints Mohamad Tabrizi as CBO
5M ago
ABEO
Abeona Therapeutics’ Strategic Advancements and Growing Demand Justify Buy Rating
PremiumRatings
Abeona Therapeutics’ Strategic Advancements and Growing Demand Justify Buy Rating
5M ago
ABEO
Abeona Therapeutics announces new treatment center for Zevaskyn in Texas
PremiumThe FlyAbeona Therapeutics announces new treatment center for Zevaskyn in Texas
5M ago
ABEO
Abeona Therapeutics: Promising Growth with ZEVASKYN’s Market Expansion and Strategic Advancements
Premium
Ratings
Abeona Therapeutics: Promising Growth with ZEVASKYN’s Market Expansion and Strategic Advancements
5M ago
ABEO
Abeona Therapeutics announces first patient treatment with ZEVASKYN
Premium
The Fly
Abeona Therapeutics announces first patient treatment with ZEVASKYN
5M ago
ABEO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >